New test could predict dangerous pregnancy complication
NCT ID NCT03289611
Summary
This study tested whether using a specific blood test (measuring the sFlt-1/PlGF ratio) could improve care for pregnant women with signs of possible preeclampsia. The goal was to see if the test helps doctors decide who truly needs hospital monitoring and who can safely avoid it, potentially improving outcomes and reducing costs. The study involved 84 women hospitalized with suspected preeclampsia before 35 weeks of pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Cochin, Maternité Port Royal
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.